Frontiers | GLP-1 receptor agonists: exploration of transformation from ...
Sep 11, 2025Abstract Glucagon-like peptide-1receptoragonists (GLP-1RAs), initially developed for type 2 diabetes and obesity, have evolved into multi-organ potential therapeutics due to their pleiotropic effects beyond glycemic control. Mechanistically,GLP-1signaling modulates immune and inflammatory pathways, regulates autophagy and pyroptosis, alleviates endoplasmic reticulum stress, and interacts ...
source: https://www.frontiersin.org